The rise of colon cancer among young people has been a mystery. Boston experts say they now have clues.

Key Points:

• Researchers from Dana-Farber Cancer Institute, Mass General Brigham, and the Broad Institute analyzed over 180 colorectal tumors across various ages, uncovering cellular-level differences that may explain the rise of colorectal cancer in younger people.
• The study found that tumors in younger patients have a higher proportion of stromal cells, which are linked to chemotherapy resistance, and distinct gene expression patterns that could lead to new therapeutic targets.
• Colorectal cancer rates among Americans under 50 have increased nearly 3% annually from 2013 to 2022, making it the leading cause of cancer death in this age group, with lifestyle factors like diet implicated but tumor biology also critical.
• The dataset, the largest of its kind and including extensive cellular analysis from young-onset patients, provides a valuable resource and research direction for developing tailored treatments and understanding disease mechanisms.
• Experts emphasize that while the study is a crucial first step, further research involving diverse patient groups is needed to fully understand early-onset colorectal cancer and advance prevention and treatment strategies.